| David H Zornow, MD | |
|
319 S Manning Blvd, Albany, NY 12208-1742 | |
| (518) 438-1019 | |
| (518) 438-0981 |
| Full Name | David H Zornow |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 319 S Manning Blvd, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457392250 | NPI | - | NPPES |
| 4S2441 | Other | EBCBS | |
| P00291580 | Other | RAILROAD MEDICARE | |
| 1099050 | Other | GHI PPO | |
| 92951 | Other | GHI HMO | |
| 4395457 | Other | AETNA | |
| 10002242 | Other | CDPHP | |
| 24131 | Other | MVP | |
| 000434059007 | Other | BLUE SHIELD OF NORTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 099024 (New York) | Primary |
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients.
"Starting this week, Ghana will vaccinate the first babies in a new campaign against rotavirus - a cause of severe diarrhea - and pneumococcal disease, which causes pneumonia, meningitis and sepsis," Reuters reports.
Actinium Pharmaceuticals, Inc. a biotechnology company focused on developing innovative, alpha particle radiotherapy targeted cancer treatments addressing major unmet medical needs, today announced that it has successfully treated the first cohort of patients in a Phase I/II study of Actimab-A in Acute Myeloid Leukemia (AML) clinical trial. Patients were treated at Memorial Sloan Kettering Cancer Center in New York City.
Africa is mismanaging its water resources," according to scientists who are in Kenya at the Sustainable Water Conference, which is organized by the Pan Africa Chemistry Network, VOA News reports.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David H Zornow, MD 319 S Manning Blvd, Albany, NY 12208-1743 Ph: (518) 438-1019 | David H Zornow, MD 319 S Manning Blvd, Albany, NY 12208-1742 Ph: (518) 438-1019 |
News Archive
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients.
"Starting this week, Ghana will vaccinate the first babies in a new campaign against rotavirus - a cause of severe diarrhea - and pneumococcal disease, which causes pneumonia, meningitis and sepsis," Reuters reports.
Actinium Pharmaceuticals, Inc. a biotechnology company focused on developing innovative, alpha particle radiotherapy targeted cancer treatments addressing major unmet medical needs, today announced that it has successfully treated the first cohort of patients in a Phase I/II study of Actimab-A in Acute Myeloid Leukemia (AML) clinical trial. Patients were treated at Memorial Sloan Kettering Cancer Center in New York City.
Africa is mismanaging its water resources," according to scientists who are in Kenya at the Sustainable Water Conference, which is organized by the Pan Africa Chemistry Network, VOA News reports.
› Verified 1 days ago
Dr. Jonah Marshall, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd Ste 106, Albany, NY 12208 Phone: 518-438-1019 Fax: 518-489-7642 | |
Rebecca Leigh O'malley, MD Urology Medicare: Medicare Enrolled Practice Location: 23 Hackett Blvd, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Brian Patrick Murray, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4 Executive Park, Albany, NY 12203 Phone: 518-489-7494 Fax: 518-489-7641 | |
Dr. Adam Shattuck Howe, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 23 Hackett Blvd # Mc-108, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Dr. Robert Charles Welliver Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 23 Hackett Blvd, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Jean G. Hollowell, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 23 Hackett Blvd, Mc 208, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Barry Kogan, Urology Medicare: Medicare Enrolled Practice Location: South Clinical Campus, 23 Hackett Blvd. (mc 208), Albany, NY 12208 Phone: 518-262-3341 |